申请人:Yoshitomi Phamaceutical Industries, Ltd.
公开号:US04414216A1
公开(公告)日:1983-11-08
There are disclosed tetrahydrofuran compounds and analogs thereof of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein X is oxygen or sulfur, R.sup.1 and R.sup.2 are each hydrogen, halogen, lower alkyl or lower alkoxy, and Am is a group of the formula: ##STR2## wherein Z is oxygen or sulfur, R.sup.3 is hydrogen or halogen, R.sup.4 is hydrogen, lower alkyl or phenyl which may be substituted by 1 to 3 substituents at any position(s) on the phenyl nucleus, each substituent being independently selected from halogen, lower alkyl and lower alkoxy, and R.sup.5 is hydrogen or lower alkyl. Such compounds are useful as neuroleptics.
本文披露了四氢呋喃化合物及其类似物的公式:##STR1##以及其药学上可接受的酸加成盐,其中X为氧或硫,R.sup.1和R.sup.2分别为氢、卤素、低烷基或低烷氧基,Am为公式:##STR2##其中Z为氧或硫,R.sup.3为氢或卤素,R.sup.4为氢、低烷基或苯基,苯基可在苯环上的任何位置被1至3个取代基取代,每个取代基独立选择自卤素、低烷基和低烷氧基,R.sup.5为氢或低烷基。这些化合物可用作神经类药物。